ORAOV1 is a probable target within the 11q13.3 amplicon in lymph node metastases from gastric adenocarcinoma

International Journal of Molecular Medicine

Volumn 29, Issue 1, 2012, Pages 81-87

  Kang, Ji Un ^a   Koo, Sun Hoe ^b  

^a Korea Nazarene University   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

Author keywords

Array CGH; Copy number gain; Gastric adenocarcinoma; High level amplification

Indexed keywords

CYCLIN D1; MOLECULAR MARKER;

AMPLICON; ARTICLE; CARCINOGENESIS; CHROMOSOME 11; CHROMOSOME 11Q; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME 20Q; CHROMOSOME 3Q; CHROMOSOME 9Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENE OVEREXPRESSION; HUMAN; LYMPH NODE METASTASIS; MALE; ONCOGENE; ORAL CANCER OVEREXPRESSED 1 GENE; PRIORITY JOURNAL; PROTO ONCOGENE; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; CHROMOSOMES, HUMAN, PAIR 11; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM PROTEINS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STOMACH NEOPLASMS;

EID: 84855161432     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.811     Document Type: Article

References (23)

1. Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362, 2006. (Pubitemid 43329250)
2. Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Waraya M, Kawamata H, Nishimiya H, Nakamura K and Watanabe M: Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer. BMC Cancer 11: 122, 2011.
3. Stacker SA, Achen MG, Jussila L, Baldwin ME and Alitalo K: Lymphangiogenesis and cancer metastasis (Review). Nat Rev Cancer 2: 573-583, 2002. (Pubitemid 37328924)
4. Otsuji E, Kuriu Y, Ichikawa D, Okamoto K, Ochiai T, Hagiwara A and Yamagishi H: Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion. World J Surg 28: 866-869, 2004. (Pubitemid 39391888)
5. Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Ono H and Akiyama H: Therapeutic strategy for scirrhous type gastric cancer. Hepatogastroenterology 52: 314-318, 2005. (Pubitemid 40282694)
6. Yashiro M, Sunami T and Hirakawa K: CD54 expression is predictive for lymphatic spread in human gastric carcinoma. Dig Dis Sci 50: 2224-2230, 2005. (Pubitemid 43106372)
7. Yashiro M, Shinto O, Nakamura K, Tendo M, Matsuoka T, Matsuzaki T, Kaizaki R, Ohira M, Miwa A and Hirakawa K: Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model. Br J Cancer 7: 1100-1106, 2009.
8. Ghadimi BM, Grade M, Liersch T, Langer C, Siemer A, Füzesi L and Becker H: Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer. Clin Cancer Res 5: 1808-1814, 2003. (Pubitemid 36554608)
9. Kang JU, Koo SH, Kwon KC, Park JW and Kim JM: Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet 182: 1-11, 2008. (Pubitemid 351323956)
10. Varella-Garcia M, Gemmill RM, Rabenhorst SH, Lotto A, Drabkin HA, Archer PA and Franklin WA: Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma. Cancer Res 58: 4701-4707, 1998. (Pubitemid 28480638)
11. Kim JI, Ju YS, Park H, Kim S, Lee S, Yi JH, Mudge J, Miller NA, Hong D, Bell CJ, Kim HS, Chung IS, Lee WC, Lee JS, Seo SH, Yun JY, Woo HN, Lee H, Suh D, Lee S, Kim HJ, Yavartanoo M, Kwak M, Zheng Y, Lee MK, Park H, Kim JY, Gokcumen O, Mills RE, Zaranek AW, Thakuria J, Wu X, Kim RW, Huntley JJ, Luo S, Schroth GP, Wu TD, Kim H, Yang KS, Park WY, Kim H, Church GM, Lee C, Kingsmore SF and Seo JS: A highly annotated whole-genome sequence of a Korean individual. Nature 460: 1011-1015, 2009.
12. Kim JI, Lee JH, Seo JS, Hwang KT, Han W, Cho J, Lee JW, Ko E, Kim EK, Jung SY, Jeong EM, Bae JY, Kang JJ, Yang SJ, Kim SW and Noh DY: Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer. Int J Cancer 123: 1807-1815, 2008.
13. Choe J, Kang JK, Bae CJ, Lee DS, Hwang D, Kim KC, Park WY, Lee JH and Seo JS: Identification of origin of unknown derivative chromosomes by array-based comparative genomic hybridization using pre- and postnatal clinical samples. J Hum Genet 52: 934-942, 2007. (Pubitemid 350112489)
14. Kang JU, Koo SH, Kwon KC, Park JW and Kim JM: Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer 9: 237, 2009.
15. Kang JU, Koo SH, Kwon KC and Park JW: Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung. Int J Oncol 37: 327-335, 2010.
16. Willenbrock H and Fridlyand J: A comparison study: applying segmentation to array-CGH data for downstream analyses. Bioinformatics 21: 4084-4091, 2005. (Pubitemid 41672097)
17. Zhu YQ, Zhu ZG, Liu BY, Chen XH, Yin HR and Wang XH: Chromosomal alterations analyzed by comparative genomic hybridization in primary gastric carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi 10: 160-164, 2007 (In Chinese).
18. Weiss MM, Kuipers EJ, Hermsen MA, van Grieken NC, Offerhaus J, Baak JP, Meuwissen SG and Meijer GA: Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications. J Pathol 199: 157-165, 2003. (Pubitemid 36176021)
19. Buffart TE, Carvalho B, Mons T, Reis RM, Moutinho C, Silva P, van Grieken NC, Vieth M, Stolte M, van de Velde CJ, Schrock E, Matthaei A, Ylstra B, Carneiro F and Meijer GA: DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics 8: 345, 2007.
20. Bizari L, Borim AA, Leite KR, Gonçalves Fde T, Cury PM, Tajara EH and Silva AE: Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers. Cancer Genet Cytogenet 65: 41-50, 2006. (Pubitemid 43254651)
21. Ghotli ZA, Serra S and Chetty R: Clear cell (glycogen rich) gastric adenocarcinoma: a distinct tubulo-papillary variant with a predilection for the cardia/gastro-oesophageal region. Pathology 39: 466-469, 2007. (Pubitemid 47450592)
22. Xavier FC, Rodini CO, Paiva KB, Destro MF, Severino P and Moyses RA: Head and neck genome Project GENCAPO, Tajara EH, Nunes FD. ORAOV1 is amplified in oral squamous cell carcinoma. J Oral Pathol Med: May 28, 2011 (Epub ahead of print). doi: 10.1111/j.1600-0714.2011.01053.x.
23. Jiang L, Zeng X, Wang Z, Ji N, Zhou Y, Liu X and Chen Q: Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells. Mol Cancer 9: 20, 2010.